Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb:121:108180.
doi: 10.1016/j.jsat.2020.108180. Epub 2020 Oct 21.

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns

Affiliations

COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns

Alexandra M Mellis et al. J Subst Abuse Treat. 2021 Feb.

Abstract

Individuals with substance use disorders (SUDs), including those in long-term recovery, and their loved ones are facing rapid changes to treatment and support services due to COVID-19. To assess these changes, the Addiction Policy Forum fielded a survey to their associated patient and family networks between April 27 and May 13, 2020. Individuals who reported a history of use of multiple substances were more likely to report that COVID-19 has affected their treatment and service access, and were specifically more likely to report both use of telehealth services and difficulties accessing needed services. These findings suggest that individuals with a history of using multiple substances may be at greater risk for poor outcomes due to COVID-19, even in the face of expansion of telehealth service access.

Keywords: Addictive behaviors; COVID-19; Polysubstance use; Substance-related disorders; Telemedicine; Treatment access.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Polysubstance use and self-reported ability to access needed services. The x axis depicts the number of substances participants endorsed using (including alcohol, nicotine, opioids, marijuana, sedatives, stimulants, and others). The y axis depicts the percent of this group reporting that they were “unable to access needed services” for treatment and recovery support, specifically due to changes in service because of COVID-19. Error bars indicate 95% confidence intervals.

References

    1. Alexander, G. C., Stoller, K. B., Haffajee, R. L., & Saloner, B. (2020). An epidemic in the midst of a pandemic: Opioid use disorder and COVID-19. Annals of Internal Medicine, M20-1141. Advance online publication. doi: 10.7326/M20-1141. - DOI - PMC - PubMed
    1. Bhalla Ish P., Stefanovics Elina A., Rosenheck Robert A. Clinical epidemiology of single versus multiple substance use disorders. Medical Care. 2017;55(9):S24–S32. doi: 10.1097/MLR.0000000000000731. - DOI - PubMed
    1. Bojdani, E., Rajagopalan, A., Chen, A., Gearin, P., Olcott, W., Shankar, V., Cloutier, A., Solomon, H., Naqvi, N. Z., Batty, N., Festin, F., Tahera, D., Chang, G., & DeLisi, L. E. (2020). COVID-19 pandemic: Impact on psychiatric care in the United States. Psychiatry Research, 289, 113069. Advance online publication. doi: 10.1016/j.psychres.2020.113069. - DOI - PMC - PubMed
    1. Columb, D., Hussain, R., & O'Gara, C. (2020). Addiction psychiatry and COVID-19: Impact on patients and service provision. Irish Journal of Psychological Medicine, 1–5. Advance online publication. doi: 10.1017/ipm.2020.47. - DOI - PMC - PubMed
    1. Connor J.P., Gullo M.J., White A., Kelly A.B. Polysubstance use: Diagnostic challenges, patterns of use and health. Current Opinion in Psychiatry. 2014;27(4):269–275. doi: 10.1097/YCO.0000000000000069. - DOI - PubMed